Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Inclusion Criteria: * Is a pre-menopausal female, 18 - 50 years; * Has documented leiomyoma(s); * Has leiomyoma-related anemia; * Has an endometrial biopsy within the screening period prior to the first dose of the test article which shows no endometrial hyperplasia; * Is willing and able to provide written informed consent and authorization to disclose protected health information. Exclusion Criteria: * Has a history of uterine surgery that would interfere with the study; * Has a condition requiring immediate or intermittent blood transfusions; * Has a known coagulation disorder; * Has a history of uterine, cervix, ovarian, or breast cancer; * Has used a selective progesterone receptor modulator or a gonadotrophin releasing hormone agonist in previous 6 months; * Has received blood transfusion within 8 weeks before the screening visit; * Has abnormal liver functions; * Is pregnant.